Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies
暂无分享,去创建一个
C. Pozzilli | P. Vermersch | B. Sharrack | H. Wiendl | D. Baker | H. Kim | R. Alroughani | R. Macdonell | D. Dive | J. Lycke | S. Eichau | D. Kantor | S. Hunter | N. Daizadeh | T. Scott | Andrew T. Chan | Luke Chung | R. Aburashed | A. Chan